“Through Navican this approach and all services, including continuous remote access to Intermountain’s tumor specialists and treatment navigators, are offered to community hospitals, independent hospital networks and other Integrated Delivery Networks,” says Ingo Chakravarty, CEO of Navican. “Patients are based in the community, across the United States and around the world, so should precision medicine, being accessible to all, not just a few.”
To this end, Navican will use Philips IntelliSpace Genomics, a comprehensive precision medicine platform built to support the implementation and scaling of informatics-heavy precision medicine programs. Resulting from more than a decade of research and development with clinical partners, it offers integrated workflows with advanced analytic capabilities and clinical decision support by unifying the whole patient picture, and streamlines collaboration across hospitals to support pathologists, oncologists, and researchers. The platform integrates N-of-One’s interpretation capabilities and extensive knowledge-bases providing ready access to a vast amount of available reference literature, guidelines, and evidence further enhancing the platform’s clinical trial matching tools.
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
“Together with Navican we aim to provide a seamless end-to-end solution using the latest technologies available,” says Louis Culot, General Manager Philips Genomics. “Hospitals and health systems will be able to send their patient samples to Navican, for advanced molecular analysis, interpretation and guidance by Intermountain. At the same time they will have access to Intermountain’s advanced services while genome informatics and data flow are fully implemented through Philips IntelliSpace Genomics, and can be further integrated with local EMR and lab systems.”
The “turnkey” precision medicine solution will first be made available within the Intermountain Healthcare network. Availability to other hospitals and healthcare systems worldwide is expected second half of 2017. The solution will be presented at Philips booth #5107 and Intermountain’ s booth #3123 at the American Society of Clinical Oncology Annual Meeting (ASCO) taking place 2 – 6 June in Chicago U.S.
Back to HCB News
